InsidersTradesSigma
Browse the complete record of transactions filed by BRADSHER NEAL C, Director. Director active across 1 companies, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 2 reports have been published. The latest transaction was filed on 25 June 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Neal C. Bradsher is a Board Member at Lineage Cell Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.